Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Gelb

Showing results (391-400 of 485) with videos related to

Pageof 49
Sort By:
Journal of Medicinal Chemistry|May 1, 2010
Second generation analogues of the cancer drug clinical candidate tipifarnib for anti-Chagas disease drug discoveryJames M Kraus, Hari Babu Tatipaka, Sarah A McGuffin, et al.
European Journal of Biochemistry|August 10, 2000
Basic residues of human group IIA phospholipase A2 are important for binding to factor Xa and prothrombinase inhibition comparison with other mammalian secreted phospholipases A2C M Mounier, P Luchetta, C Lecut, et al.
Journal of Biomolecular Screening|May 6, 2016
Fluorometric High-Throughput Screening Assay for Secreted Phospholipases A2 Using Phospholipid VesiclesHeather Ewing, Virneliz Fernández-Vega, Timothy P Spicer, et al.
Plos One|January 15, 2015
Detection and quantification of microparticles from different cellular lineages using flow cytometry. Evaluation of the impact of secreted phospholipase A2 on microparticle assessmentMatthieu Rousseau, Clemence Belleannee, Anne-Claire Duchez, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2005
Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutationShao H Yang, Martin O Bergo, Julia I Toth, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 22, 2001
Glycolysis as a target for the design of new anti-trypanosome drugsC L Verlinde, V Hannaert, C Blonski, et al.
Neurobiology of Disease|September 16, 2022
Galactosylceramidase deficiency and pathological abnormalities in cerebral white matter of Krabbe diseaseDiego Iacono, Shunsuke Koga, Hui Peng, et al.
Genome Biology|July 21, 2023
Predicting disease severity in metachromatic leukodystrophy using protein activity and a patient phenotype matrixMarena Trinidad, Xinying Hong, Steven Froelich, et al.
The Journal of Biological Chemistry|March 6, 2002
Cellular arachidonate-releasing function and inflammation-associated expression of group IIF secretory phospholipase A2Makoto Murakami, Kumiko Yoshihara, Satoko Shimbara, et al.
Biochemical Society Transactions|October 10, 1998
Binding of bee venom and human group IIa phospholipases A2 to membranes: a minor role for electrostaticsY Lin, F Ghomashchi, R Nielsen, et al.
Pageof 49

Showing results (391-400 of 485) with videos related to

Sort By:
Pageof 49
Journal of Medicinal Chemistry|May 1, 2010
Second generation analogues of the cancer drug clinical candidate tipifarnib for anti-Chagas disease drug discoveryJames M Kraus, Hari Babu Tatipaka, Sarah A McGuffin, et al.
European Journal of Biochemistry|August 10, 2000
Basic residues of human group IIA phospholipase A2 are important for binding to factor Xa and prothrombinase inhibition comparison with other mammalian secreted phospholipases A2C M Mounier, P Luchetta, C Lecut, et al.
Journal of Biomolecular Screening|May 6, 2016
Fluorometric High-Throughput Screening Assay for Secreted Phospholipases A2 Using Phospholipid VesiclesHeather Ewing, Virneliz Fernández-Vega, Timothy P Spicer, et al.
Plos One|January 15, 2015
Detection and quantification of microparticles from different cellular lineages using flow cytometry. Evaluation of the impact of secreted phospholipase A2 on microparticle assessmentMatthieu Rousseau, Clemence Belleannee, Anne-Claire Duchez, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2005
Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutationShao H Yang, Martin O Bergo, Julia I Toth, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 22, 2001
Glycolysis as a target for the design of new anti-trypanosome drugsC L Verlinde, V Hannaert, C Blonski, et al.
Neurobiology of Disease|September 16, 2022
Galactosylceramidase deficiency and pathological abnormalities in cerebral white matter of Krabbe diseaseDiego Iacono, Shunsuke Koga, Hui Peng, et al.
Genome Biology|July 21, 2023
Predicting disease severity in metachromatic leukodystrophy using protein activity and a patient phenotype matrixMarena Trinidad, Xinying Hong, Steven Froelich, et al.
The Journal of Biological Chemistry|March 6, 2002
Cellular arachidonate-releasing function and inflammation-associated expression of group IIF secretory phospholipase A2Makoto Murakami, Kumiko Yoshihara, Satoko Shimbara, et al.
Biochemical Society Transactions|October 10, 1998
Binding of bee venom and human group IIa phospholipases A2 to membranes: a minor role for electrostaticsY Lin, F Ghomashchi, R Nielsen, et al.
Pageof 49